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Background:Although the effects of opioids on intracranial pressure (ICP) have long been
a subject of controversy, they are frequently administered to patients with severe head
trauma. We present a patient with an uncommon paradoxical response to opioids.
Case Report: A patient with refractory intracranial hypertension after closed head injury
was managed with standard medical therapy with only transient decreases in the ICP.
Only after discontinuation of opiates did the ICP become manageable without metabolic
suppression and rescue osmotic therapy, implicating opiates as the etiology of refractory
intracranial hypertension in this patient.
Conclusion:Clinicians should consider opioids as a contributing factor in malignant intracra-
nial hypertension when findings on neuroimaging do not explain persistent and refractory
intracranial hypertension.
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INTRODUCTION
Although opioids frequently are administered to patients with
severe head trauma, the effects of such drugs on intracranial pres-
sure (ICP) are controversial (Marx et al., 1989; Cuillerier et al.,
1990; Weinstabl et al., 1991; Markovitz et al., 1992). Fentanyl and
other opiates may cause a direct increase in ICP in certain patients
although the mechanism and clinical significance of this effect is
currently unknown (Sperry et al., 1992; Tobias, 1994; de Nadal
et al., 2000). Despite these isolated reports, widespread experience
supports the safety of fentanyl for patients with elevated ICP in
head trauma.
CASE REPORT
Our patient was a 19-year-old woman who was the restrained dri-
ver in a roll-over accident at highway speed. Her Glasgow coma
scale was 4 with extensor posturing. She was sedated, paralyzed,
intubated, and transported to our hospital as a level 1 trauma. Her
medical history was unremarkable.
CT imaging of the head revealed multiple punctate hemor-
rhagic lesions, early effacement of the gray-white junction and
diffuse traumatic subarachnoid hemorrhage (Figure 1).
An intraparenchymal ICP monitor was placed with initial read-
ings of 23–25 mmHg. Supportive care was instituted with midline
placement of the head and elevation of the head to 30˚, seda-
tion with propofol and analgesia with fentanyl. She required bolus
doses of 20% mannitol for ICP surges with physical stimulation.
On hospital day 3 she developed refractory intracranial hyperten-
sion and fever which persisted through hospital day 12 despite
aggressive medical management. She was very sensitive to any
physical stimulation, particularly changes in position or tracheal
suctioning which resulted in ICP spikes. Osmotic therapy includ-
ing alternating boluses of 20% mannitol and 23% saline were
used to treat ICP surges. Maintenance fluids were changed to 3%
saline solution in order to induce mild hypernatremia and decrease
the need for rescue osmotic therapy. We induced mild hypother-
mia (35˚C) using the Arctic Sun device (Bard, Inc., Atlanta, GA,
USA) as an adjuvant to osmotic therapy with pharmacological
neuromuscular paralysis to control the shivering response. Several
attempts at reducing the degree of metabolic suppression by slowly
increasing the core body temperature and lightening the degree
of neuromuscular paralysis and propofol requirement failed. She
consistently required a temperature under 35˚C and a dose of
Propofol greater than 40 mcg/kg/min to maintain control of her
ICP. A repeat CT scan on hospital day 11 (Figure 2) did not show
significant cerebral edema to explain the persistent and refrac-
tory intracranial hypertension. It was noted that despite adequate
hydration and apparent intravascular euvolemia, she was consis-
tently tachycardic with intermittent periods of hypertension. This
raised the possibility of sympathetic hyperactivity for which she
was started on propranolol with only marginal decrease in the
heart rate. On hospital day 12 a bolus of 4 mg of morphine was
administered following a rise in ICP to 30 mmHg in an effort to
determine if the elevation in ICP was due to a sympathetic surge.
Immediately following the administration of morphine the ICP
rose steadily from a baseline of 30 mmHg up to 55 mmHg over
3 min without any appreciable change in heart rate or blood pres-
sure. The transient but significant rise in ICP was easily managed
with hyperventilation and administration of 1 g/kg of 20% manni-
tol. Following this unexpected surge in ICP after administration of
morphine, the fentanyl infusion she had been receiving since hos-
pital day 1 was discontinued with an ensuing decline in ICP over
the next 24 h which reached single digits for the first time since
monitoring was started. No new interventions were introduced
during this period. Parallel with the normalization of ICP was
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FIGURE 1 | CT scan of the head on hospital day 1 demonstrates poor
gray-white junction differentiation suggestive of diffuse cerebral
edema.There are scattered areas of subarachnoid hemorrhage in multiple
frontal and parietal sulci as well as scattered areas of hyperattenuation at
the gray-white junction in the frontal and parietal lobes which may be
related to contusions or diffuse axonal injury. Also seen is a large left
parietal scalp hematoma.
a resolution of her persistent sinus tachycardia and intermittent
arterial hypertension. Permitting transient increases of ICPs up to
30 mmHg after stimulation, we were able to rapidly resume nor-
mothermia (36.5˚C), discontinue neuromuscular paralysis, and
transition from propofol to a low dose of midazolam without the
need for rescue doses of hyperosmolar therapy (Figure 3). Before
discontinuation of the ICP monitoring, her ICPs had steadily
settled below 15 mmHg.
DISCUSSION
Morphine and fentanyl are the most commonly used opioids
for analgesia in patients suffering head trauma (Shapiro et al.,
1995). Studies in humans have shown varying effects of opioid
administration on ICP with some patients developing substantial
transient rises after bolus dosing (Moss et al., 1978; Marx et al.,
1989; Cuillerier et al., 1990; Weinstabl et al., 1991; Markovitz
et al., 1992; Sperry et al., 1992; Albane‘se et al., 1999). Most
of these studies find a parallel decrease in mean arterial blood
pressure (MAP). The decrease in MAP has been hypothesized to
be the mechanism of increased ICP observed after administra-
tion of opioids in patients with reduced intracranial compliance
FIGURE 2 | CT scan of the head on hospital day 11 demonstrates
expected evolution of the previously noted cortical contusions,
subdural hematomas, and changes of diffuse axonal injury. No new
hemorrhage, mass effect, hydrocephalus, or CT radiographic evidence of
acute ischemic injury. Stable diffuse cerebral swelling with partial
effacement of the suprasellar cistern.
and intact autoregulation through a pathway of vasodilation and
increased blood volume (Werner et al., 1995). Our patient did
not have a concomitant decrease in MAP making this mechanism
improbable.
Another possible mechanism is a direct vasodilatory effect asso-
ciated with opioid administration (Wahl, 1985; Thorogood and
Armstead, 1995). The fact that she was so sensitive to hypothermia
and propofol administration, interventions which reduce cere-
bral metabolism and blood volume, also support a theory of
increased blood volume due to vasodilatation. Opioid-induced
rigidity has been suggested as a possible mechanism of increased
ICP following opiate administration due to increasing cerebral
metabolic rate for oxygen (CMRo2), cerebral blood flow (CBF),
and/or cerebral blood volume (Benthuysen et al., 1988). This is
unlikely, however, to have been a significant contributing factor
in our patient because she was under nearly complete neuro-
muscular blockade during the period of refractory intracranial
hypertension.
An alternative mechanism which could induce increased ICP
indirectly is opioid-induced histamine release by a vasodila-
tory effect and resultant increased CBF. Our patient consistently
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FIGURE 3 | Intracranial pressure is plotted over time.The timing of
morphine and fentanyl administration are shown. Rescue doses of
hyperosmolar therapy are plotted at the bottom of the graph.
responded to osmotic agents but always briefly. This was likely due
to a rheologic reduction in cerebral blood volume rather than to
osmotic diuresis as she did not have evidence of significant cere-
bral edema on imaging. While this may explain the sudden increase
in ICP following morphine administration in our patient, it does
not fully explain the reduction in ICP after discontinuation of
fentanyl infusion as fentanyl does not typically trigger histamine
release (Flacke et al., 1987). This mechanism is also made unlikely
by the lack of significant hemodynamic change associated with
the rise in ICP. Non-opiate related reasons such as the natural
history of the disease may exist to explain the phenomenon we
observed.
CONCLUSION
Although the mechanism refractory intracranial hypertension
in our patient is unclear, the sudden surge in ICP follow-
ing morphine administration in addition to the resolution
of refractory intracranial hypertension following discontinua-
tion of fentanyl infusion strongly argues for a causal relation-
ship. The mechanism of the increased ICP in our patient is
unclear, however, it is reasonable to assume that it could be
related to intrinsic properties of opioids such as direct cere-
bral vasodilation combined with some predisposition in our
patient. Despite widespread use of opiates in patients with head
injury, we encourage the clinician to consider opiates as a pos-
sible cause for refractory intracranial hypertension in patients
at risk for decreased intracranial compliance, particularly if a
sufficient explanation for persistent intracranial hypertension is
lacking.
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